ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Thomas Jefferson University
Assistance Publique - Hôpitaux de Paris
Thomas Jefferson University
Mayo Clinic
NRG Oncology
Universitaire Ziekenhuizen KU Leuven
Mayo Clinic
Mayo Clinic
Mayo Clinic
Assiut University
Mayo Clinic
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Baylor College of Medicine